This is an info Alert.
  • Home
  • Product
  • Blog
  • Contact

Discover laboratory and life science products for your research. Search our catalog by product name, keyword or catalog number and find the right solution for your laboratory.

Search thousands of research products

Product information & research resources

Support for your product inquiries

Products
All productsSearch products
Resources
ArticlesFAQs
Company
About usContact us
Legal
Terms & conditionsPrivacy policy

© 2026 Gentaur. All rights reserved.
ProductsArticlesContact
0
  1. Home
  2. Products
  3. ETS1 / (Marker of Tumor Metastasis) (ETS1/1282), CF594 conjugate, 0.1mg/mL
1/0

ETS1 / (Marker of Tumor Metastasis) (ETS1/1282), CF594 conjugate, 0.1mg/mL

Product ID: 902012


Gentaur Catalog Number

GTR00917196
Select size

1x 500 µL

$882.27
​
Selected
1x 500 µL

$882.27

1


Documents
Product Datasheet

ETS1 proto-oncogene is an important transcription factor that plays a role in cell proliferation and differentiation. ETS1 is related to the growth of carcinoma cells by its regulation of the transcription of matrix metalloproteinases and urokinase-type plasminogen activator. The processes of tumor invasion and metastasis depend on the increased proteolytic activity of the invading tumor cells that may involve matrix metalloproteinases, cathepsins B and D and plasminogen activator in the metastatic cascade. ETS1 is preferentially expressed in lymphoid cells, where it is essential for the maintenance of the normal pool of resting T and B cells. ETS1 expression level and distribution are differentially controlled in resting, activated and apoptotic lymphocytes.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.